Pfizer
Page 8 of 37
HealthPushback grows against fourth COVID vaccine doses, with experts urging caution over expanding booster campaigns
By David MeyerJanuary 11, 2022
HealthPfizer is testing a hybrid COVID vaccine, mixing its original with a new formulation that shields against Omicron
By Riley Griffin and BloombergJanuary 10, 2022
By Erika Fry and Nicolas RappJanuary 5, 2022
By Lauran Neergaard, Mike Stobbe and The Associated PressJanuary 5, 2022
By Lauran Neergaard and The Associated PressJanuary 3, 2022
By Jeremy KahnDecember 29, 2021
HealthModerna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries
By David MeyerDecember 27, 2021
By Matthew Perrone and The Associated PressDecember 23, 2021
By Matthew Perrone and The Associated PressDecember 22, 2021
HealthIsrael to give fourth COVID vaccine doses to combat Omicron, despite lack of data on second boosters
By David MeyerDecember 22, 2021
By Josh Wingrove, Jennifer Jacobs, Robert Langreth and BloombergDecember 21, 2021
HealthEU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares
By Christiaan HetznerDecember 20, 2021
HealthEurope taps Pfizer and BioNTech to provide 180 million more vaccines to face ‘ferocious’ Omicron threat
By Christiaan HetznerDecember 17, 2021
Most Popular
